Bioprocessing
Upstream, downstream, scale-up and biomanufacturing.
Latest Bioprocessing news
Bioprocessing Applications Lab (BPAL) A Partner-Focused Case Study In Solving Downstream Purification Challenges
Read at Bioprocess Online →Smart bioreactor for advanced osteochondral tissue models | SYNERGIES Project | Results in Brief | HORIZON
Read at CORDIS →MilliporeSigma opens bioprocessing production center in Daejeon, South Korea
Read at ChemEngOnline →Alivus Life Sciences Q2 FY27 Profit Jumps 51% to Rs 197 Crore; CDMO Revenue Up 80% as Solapur API Site Nears Start
Read at eHealth Magazine →Laurus rallies 19% in 4 days; zooms 111% YTD; what's driving CDMO stock?
Read at Business Standard →Laurus Labs Q2 FY27 Profit Jumps 126% to ₹441 Crore as CDMO Revenue Surges 75%; Picks Up 60% Stake in Canada's Galenvs
Read at eHealth Magazine →From the knowledge base

StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance
Shares of gene editing therapy companies mostly surged this past week on two growth catalysts: Data readouts at the European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress, and the FDA's new draft guidance for personalized gene therapies.

How the NEXTY Awards open doors to valuable food service partnerships
Corporate food service providers offer bulk purchases, direct feedback and exposure to thousands of consumers. Here's how the NEXTY Awards can help you break in.

Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more
Hello and welcome back to a spooky Halloween edition of Endpoints Weekly! Sorry to all the candy corn lovers out there, but just noting that they’re actually made with bug secretions. The Atlantic has all ...

Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
According to the company, the funds will support the next phase of its growth in enabling autonomous science in labs and biopharmaceutical companies using its AI and robotics systems.

100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-cell multimodal dataset combining single-cell and proteomic data to advance AI-driven immune modeling, drug discovery, and therapeutic target identification.

Sanofi may seek higher European drug prices, not withhold launches, under Trump deal
While some of Europe’s biggest drugmakers have warned that President Donald Trump’s pricing policies could leave European patients waiting longer for new medicines, Sanofi is taking a different approach. ...